Status:

COMPLETED

Acetaminophen Before Vaccines for Infants Study (AVIS)

Lead Sponsor:

Kaiser Permanente

Collaborating Sponsors:

Centers for Disease Control and Prevention

Conditions:

Fever

Eligibility:

All Genders

6-9 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to see whether giving acetaminophen (the medicine in Tylenol) for routine infant vaccinations is helpful in preventing fever or other symptoms.

Detailed Description

Post-vaccination fever occurs in up to 40% of infants receiving routinely recommended childhood vaccinations. Although serious events are rare, post-vaccination fever causes discomfort for the child, ...

Eligibility Criteria

Inclusion

  • Child is a current Group Health enrollee.
  • Child will be seen at a Group Health clinic for a Well Child visit that is expected to include 2 or more vaccines after 6 wks and before 10 months of age.

Exclusion

  • If child was born at less than 36 weeks of gestation, the child is not eligible until 4 months of age or older.
  • If the child's birth weight was less than 5.5 pounds (2500 grams), the child is not eligible until 4 months of age or older.

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

374 Patients enrolled

Trial Details

Trial ID

NCT00325819

Start Date

May 1 2006

End Date

September 1 2009

Last Update

October 13 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Group Health Research Institute

Seattle, Washington, United States, 98101